The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.34
Bid: 42.10
Ask: 42.16
Change: 0.04 (0.09%)
Spread: 0.06 (0.143%)
Open: 41.40
High: 42.54
Low: 41.40
Prev. Close: 42.30
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

3 Oct 2019 07:00

RNS Number : 5770O
Assura PLC
03 October 2019
 

3 October 2019

Assura plc

 

Trading Update

For the first half of the year to 30 September 2019

 

Assura's high-quality portfolio further enhanced; GPI acquisition successfully integrated

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first half of the year to 30 September 2019.

 

Jonathan Murphy, CEO, said:

"Assura has had a very active first six months of the reporting year as we continue to build on our strong progress. The acquisition of GPI, announced in May this year, has been integrated into Assura successfully, and further strengthens our market-leading position, putting us in a better place to provide GPs with the real estate that they need to help alleviate the stresses in the NHS.

 

"We remain confident in our outlook for the year and look forward to sharing a fuller update at our interim results in November."

 

Continued improvement to strong portfolio, supported by GPI acquisition

·; Current portfolio of 560 properties.

·; Two developments completed (Darley Dale & South Woodham Ferrers) at a cost of £8.4 million and five moved to on site (Canterbury, St Leonards, Hereford, Launceston and Bournville); total of 14 developments on site at the period end with a total development cost of £69 million.

·; Nine acquisitions completed in the period at a cost of £34.3 million.

·; 14 disposals completed for £18 million cash consideration at a small premium to book value at March 2019.

 

Strong development pipeline offers significant opportunity

·; Immediate development pipeline of £72 million.

·; Immediate acquisitions pipeline of £65 million, compared with £41 million at March 2019.

·; Total immediate pipeline, including on site developments, worth £206 million, up from £142 million at year end.

 

Continued rent roll growth

·; 13 lease re-gears agreed on £0.9 million of rent, adding weighted average of 8.5 years WAULT to those leases.

·; Annualised rent roll at £104.4 million taking account of additions, disposals and rent reviews.

 

Strong financials provide solid platform as the group continues to grow

·; Issued £107 million of privately placed notes announced on 8 August 2019 in two series (10 and 15 years' maturities) with a weighted average interest rate of 2.3%.

·; As at 30 September 2019 gross debt stood at £757 million with undrawn facilities of £250 million.

 

Results for the six months ended 30 September 2019 will be announced on 12 November 2019.

 

 

ENDS

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFO

David Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFEEIILFIIA
Date   Source Headline
1st Feb 20167:00 amRNSTotal Voting Rights
29th Jan 20162:00 pmRNSNotification of Vesting of Share Award to PDMR
22nd Jan 20167:00 amRNSAcquisition and Issue of Consideration Shares
19th Jan 20162:12 pmRNSScrip Dividend Declaration
6th Jan 20167:00 amRNSDirector/PDMR Shareholding
24th Dec 20157:00 amRNSScrip Calculation Price
22nd Dec 20155:06 pmRNSDirector/PDMR Shareholding
9th Dec 20157:00 amRNSNotice of Dividend & Introduction of Scrip Scheme
19th Nov 20157:00 amRNSInterim Results 2015
12th Nov 20157:00 amRNSDebt Redemption
2nd Nov 201512:14 pmRNSAcquisition and Issue of Consideration Shares
15th Oct 20151:53 pmRNSNotification of Major Interest in Shares
14th Oct 20155:10 pmRNSDirector/PDMR Shareholdings
13th Oct 201511:58 amRNSConfirmation of Quarterly Interim Dividend
12th Oct 20152:27 pmRNSResult of General Meeting
12th Oct 20157:00 amRNSResult of Proposed Share Issue
1st Oct 20159:59 amRNSTotal Voting Rights
28th Sep 20155:49 pmRNSPDMR Sale of Shares under VCP
25th Sep 20155:50 pmRNSAward and Exercise of Nil Cost Options under VCP
24th Sep 20154:53 pmRNSPublication of Prospectus
24th Sep 20157:00 amRNSProposed Share Issue and Notice of GM
8th Sep 20155:41 pmRNSTR1 Notification of Major Interest in Shares
13th Aug 201511:02 amRNSAnnual Information Update
21st Jul 20155:44 pmRNSResult of AGM
21st Jul 20154:00 pmRNSAcquisition and Issue of Consideration Shares
21st Jul 20157:00 amRNSTrading Update
18th Jun 20157:00 amRNSConfirmation of Quarterly Interim Dividend
17th Jun 20152:53 pmRNSCompany Secretary Appointment
2nd Jun 201512:58 pmRNSNotification of Major Interest In Shares
21st May 20157:00 amRNSFull Year Results
7th May 201512:10 pmRNSNotification of Major Interest in Shares
1st May 20153:28 pmRNSNotice of Results
15th Apr 20154:11 pmRNSNotification of Major Interest in Shares
14th Apr 20155:39 pmRNSNotification of Major Interest in Shares
2nd Apr 20155:09 pmRNSConfirmation of Quarterly Interim Dividend
26th Mar 201511:16 amRNSDirector/PDMR Shareholding
6th Mar 20158:50 amRNSEPRA Index Inclusion
4th Feb 20157:00 amRNSTrading Update
30th Jan 20159:42 amRNSNotification of Major Interest in Shares
29th Jan 20153:56 pmRNSNotification of Vesting of Share Award to PDMR
28th Jan 20158:21 amRNSAdmission of Assura plc shares
27th Jan 20151:53 pmRNSCourt hearing approves new corporate structure
23rd Jan 20152:27 pmRNSPublication of Prospectus
23rd Jan 201511:08 amRNSTR-1: Notification of Major Interest in Shares
14th Jan 201512:42 pmRNSResults of Shareholder Meetings
12th Jan 20157:00 amRNSForward funding and acquisition update
7th Jan 20157:00 amRNSAssura completes Sudbury Community Health Centre
17th Dec 20145:27 pmRNSPosting of Shareholder Circular & Meeting Notices
17th Dec 201410:16 amRNSAcquisition of a medical centre for £10.1 million
16th Dec 201412:12 pmRNSNew Corporate Structure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.